Microbiology
Main Filters
Microbiology
| BIOMERIEUX , INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| B.50 | 0 | - | ||
| VITEK® 2 AST-GN14 | 0 | - | ||
| VITEK® 2 AST-GN48 | 0 | - | ||
| VITEK® 2 AST-GN49 | 0 | - | ||
| VITEK® 2 AST-GN66 | 0 | - | ||
| VITEK® 2 AST-GN67 | 0 | - | ||
| VITEK® 2 AST-GN68 | 0 | - | ||
| VITEK® 2 AST-GN69 | 0 | - | ||
| VITEK® 2 AST-GN70 | 0 | - | ||
| VITEK® 2 AST-GN71 | 0 | - | ||
| VITEK® 2 AST-GN72 | 0 | - | ||
| VITEK® 2 AST-GN73 | 0 | - | ||
| VITEK® 2 AST-GN74 | 0 | - | ||
| VITEK® 2 AST-GN75 | 0 | - | ||
| VITEK® 2 AST-GN76 | 0 | - | ||
| VITEK® 2 AST-GN77 | 0 | - | ||
| VITEK® 2 AST-GN79 | 0 | - | ||
| VITEK® 2 AST-GN80 | 0 | - | ||
| VITEK® 2 AST-GN81 | 0 | - | ||
| VITEK® 2 AST-GN82 | 0 | - | ||
| VITEK® 2 AST-GN83 | 0 | - | ||
| VITEK® 2 AST-GN84 | 0 | - | ||
| VITEK® 2 AST-GN86 | 0 | - | ||
| VITEK® 2 AST-GN87 | 0 | - | ||
| VITEK® 2 AST-GN90 | 0 | - | ||
| VITEK® 2 AST-GN91 | 0 | - | ||
| VITEK® 2 AST-GN92 | 0 | - | ||
| VITEK® 2 AST-GN93 | 0 | - | ||
| VITEK® 2 AST-GP67 | 0 | - | ||
| VITEK® 2 AST-GP68 | 0 | - | ||
| VITEK® 2 AST-GP72 | 0 | - | ||
| VITEK® 2 AST-GP74 | 0 | - | ||
| VITEK® 2 AST-GP75 | 0 | - | ||
| VITEK® 2 AST-XN04 | 0 | - | ||
| VITEK® 2 AST-XN06 | 0 | - | ||
| VITEK® 2 GN | 0 | - | ||
| VITEK® 2 GP | 0 | - | ||
| VITEK®2 AST-GN89 | 0 | - | ||
| VITEK®2 AST-GP71 | 0 | - | ||
| BIOMERIEUX SA | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| Etest® AMOXICILLIN | 0 | - | ||
| Etest® CEFOTETAN | 0 | - | ||
| ETEST® Ceftaroline (CPT) | 0 | - | ||
| Etest® ERTAPENEM | 0 | - | ||
| ETEST® ESBL Cefotaxime/cefotaxime + clavulanic acid (CT/CTL) | 0 | - | ||
| ETEST® ESBL Ceftazidime/ceftazidime + clavulanic acid (TZ/TZL) | 0 | - | ||
| ETEST® Fosfomycin (FM) | 0 | - | ||
| ETEST® Gentamicin (GM) | 0 | - | ||
| Etest® MEROPENEM | 0 | - | ||
| Etest® TIGECYCLINE | 0 | - | ||
| Etest® TOBRAMYCIN | 0 | - | ||
13,132 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Etest® AMOXICILLIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Ceftaroline (CPT)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® TIGECYCLINE
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® TOBRAMYCIN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® ESBL Ceftazidime/ceftazidime + clavulanic acid (TZ/TZL)
BIOMERIEUX SA
Etest is a quantitative technique for determining the MIC of antimicrobial agents against microorganisms and for detection of resistance mechanisms.
0
-
ETEST® ESBL Cefotaxime/cefotaxime + clavulanic acid (CT/CTL)
BIOMERIEUX SA
Etest is a quantitative technique for determining the MIC of antimicrobial agents against microorganisms and for detection of resistance mechanisms.
0
-
Etest® ERTAPENEM
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Fosfomycin (FM)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® MEROPENEM
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
ETEST® Gentamicin (GM)
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
Etest® CEFOTETAN
BIOMERIEUX SA
Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
0
-
VITEK® 2 AST-XN06
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-XN04
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN93
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN92
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN91
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN90
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK®2 AST-GN89
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN87
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN86
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN84
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN83
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN82
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN81
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN80
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN79
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN77
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN76
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN75
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN74
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN73
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN72
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN71
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN70
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN69
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN68
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN67
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN66
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN49
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN48
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GN14
BIOMERIEUX , INC.
VITEK ® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-GP74
BIOMERIEUX , INC.
VITEK ® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae
0
-
VITEK® 2 AST-GP68
BIOMERIEUX , INC.
VITEK ® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 to determine susceptibility of Staphylococcus spp., Enterococcus spp., & S. agalactiae
0
-
VITEK® 2 AST-GP75
BIOMERIEUX , INC.
VITEK ® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 to determine susceptibility of Staphylococcus spp., Enterococcus spp., & S. agalactiae
0
-
VITEK® 2 AST-GP72
BIOMERIEUX , INC.
VITEK ® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae
0
-
VITEK®2 AST-GP71
BIOMERIEUX , INC.
VITEK ® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 to determine susceptibility of Staphylococcus spp., Enterococcus spp., & S. agalactiae
0
-
VITEK® 2 AST-GP67
BIOMERIEUX , INC.
VITEK ® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae
0
-
VITEK® 2 GP
BIOMERIEUX , INC.
VITEK® 2 GP Identification Card is intended for use with the VITEK 2 Systems for the automated identification of most significant Gram-positive organisms
0
-
VITEK® 2 GN
BIOMERIEUX , INC.
The VITEK® 2 GN Identification Card is intended for use with the VITEK 2 to determine ID of clinically important Gram negative bacteria